Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) has released an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical General Factory, has received approval from the National Medical Products Administration for its Azithromycin Capsule, which has passed the generic drug quality and therapeutic consistency evaluation. This approval marks a significant milestone for the company, ensuring that their generic drug meets the required standards for quality and efficacy.
For further insights into HK:0874 stock, check out TipRanks’ Stock Analysis page.
